{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:03:02Z","timestamp":1754193782366},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00393-011-0755-0","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T17:03:26Z","timestamp":1314119006000},"page":"464-472","source":"Crossref","is-referenced-by-count":12,"title":["Kardiovaskul\u00e4re Komorbidit\u00e4t und ihre Risikofaktoren bei rheumatoider Arthritis"],"prefix":"10.1007","volume":"70","author":[{"given":"S.","family":"Kleinert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,10]]},"reference":[{"key":"755_CR1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/ar2751","volume":"11","author":"Baka","year":"2009","unstructured":"Baka Z, Buzas E, Nagy G (2009) Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther 11:238","journal-title":"Arthritis Res Ther"},{"key":"755_CR2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.amjcard.2007.11.076","volume":"101","author":"Banerjee","year":"2008","unstructured":"Banerjee S, Compton AP, Hooker RS et al (2008) Cardiovascular outcomes in male veterans with rheumatoid arthritis. Am J Cardiol 101:1201\u20131205","journal-title":"Am J Cardiol"},{"key":"755_CR3","first-page":"8","volume":"Cardiol","author":"B\u00f6hm","year":"2007","unstructured":"B\u00f6hm M, Laufs U, Hamm C et al (2007) Position paper on statin therapy. Clin Res Cardiol (Suppl 2):8\u201315","journal-title":"Clin Res"},{"key":"755_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","volume":"78","author":"Boyer","year":"2011","unstructured":"Boyer JF, Gourraud PA, Cantagrel A et al (2011) Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 78:179\u2013183","journal-title":"Joint Bone Spine"},{"key":"755_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3899\/jrheum.080404","volume":"36","author":"Brady","year":"2009","unstructured":"Brady SR, De Courten B, Reid CM et al (2009) The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol 36:34\u201340","journal-title":"J Rheumatol"},{"key":"755_CR6","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","volume":"368","author":"Cannon","year":"2006","unstructured":"Cannon CP, Curtis SP, Fitzgerald GA et al (2006) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 368:1771\u20131781","journal-title":"Lancet"},{"key":"755_CR7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard.2008.101964","volume":"68","author":"Choy","year":"2009","unstructured":"Choy E, Sattar N (2009) Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis 68:460\u2013469","journal-title":"Ann Rheum Dis"},{"key":"755_CR8","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH et al (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107:3133\u20133140","journal-title":"Circulation"},{"key":"755_CR9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","volume":"56","author":"Davis","year":"2007","unstructured":"Davis JM 3rd, Maradit Kremers H, Crowson CS et al (2007) Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 56:820\u2013830","journal-title":"Arthritis Rheum"},{"key":"755_CR10","unstructured":"Deutsche Hochdruckliga e.V. DHL\u00ae, Deutsche Hypertonie Gesellschaft (2008) Leitlinien zur Behandlung der arteriellen Hypertonie. AWMF-Leitlinien-Register-Nr. 046\/001 (Stand Juni 2008)"},{"key":"755_CR11","unstructured":"Deutsche Hochdruckliga e.V. DHL\u00ae, Deutsche Hypertonie Gesellschaft (2010) Zielblutdruckwerte bei Patienten mit Diabetes mellitus. Stellungnahme vom 07. September 2010"},{"key":"755_CR12","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","volume":"56","author":"Dixon","year":"2007","unstructured":"Dixon WG, Watson KD, Lunt M et al (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56:2905\u20132912","journal-title":"Arthritis Rheum"},{"key":"755_CR13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/hrt.2006.097816","volume":"93","author":"Edwards","year":"2007","unstructured":"Edwards CJ, Syddall H, Goswami R et al (2007) The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men. Heart 93:1263\u20131267","journal-title":"Heart"},{"key":"755_CR14","first-page":"III","volume":"94","author":"Gohlke","year":"2005","unstructured":"Gohlke H, Von Schacky C (2005) Total risk for cardiovascular disease. At what point is medical prophylactic medication useful? Z Kardiol 94(Suppl 3):III\/6\u201310","journal-title":"Z Kardiol"},{"key":"755_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","volume":"57","author":"Gonzalez-Gay","year":"2007","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ et al (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125\u2013132","journal-title":"Arthritis Rheum"},{"key":"755_CR16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.2007.076760","volume":"68","author":"Goodson","year":"2009","unstructured":"Goodson NJ, Brookhart AM, Symmons DP et al (2009) Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann Rheum Dis 68:367\u2013372","journal-title":"Ann Rheum Dis"},{"key":"755_CR17","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/ard.2010.129916","volume":"70","author":"Greenberg","year":"2011","unstructured":"Greenberg JD, Kremer JM, Curtis JR et al (2011) Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 70:576\u2013582","journal-title":"Ann Rheum Dis"},{"key":"755_CR18","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/art.24855","volume":"60","author":"Holmqvist","year":"2009","unstructured":"Holmqvist ME, Wedren S, Jacobsson LT et al (2009) No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. Arthritis Rheum 60:2861\u20132869","journal-title":"Arthritis Rheum"},{"key":"755_CR19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2796.2010.02260.x","volume":"268","author":"Holmqvist","year":"2010","unstructured":"Holmqvist ME, Wedren S, Jacobsson LT et al (2010) Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 268:578\u2013585","journal-title":"J Intern Med"},{"key":"755_CR20","first-page":"1213","volume":"32","author":"Jacobsson","year":"2005","unstructured":"Jacobsson LT, Turesson C, Gulfe A et al (2005) Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32:1213\u20131218","journal-title":"J Rheumatol"},{"key":"755_CR21","first-page":"A1808","volume":"102","author":"Keil","year":"2005","unstructured":"Keil U, Fitzgerald AP, Gohlke H et al (2005) Risikoabsch\u00e4tzung t\u00f6dlicher Herz-Kreislauf-Erkrankungen. Die neuen SCORE-Deutschland-Tabellen f\u00fcr die Prim\u00e4rpr\u00e4vention. Dtsch Arztebl 102:A1808\u2013A1812","journal-title":"Dtsch Arztebl"},{"key":"755_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2010.142133","volume":"70","author":"Kitas","year":"2011","unstructured":"Kitas GD, Gabriel SE (2011) Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 70:8\u201314","journal-title":"Ann Rheum Dis"},{"key":"755_CR23","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/ard.2009.124180","volume":"69","author":"Klarenbeek","year":"2010","unstructured":"Klarenbeek NB, Van Der Kooij SM, Huizinga TJ et al (2010) Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial. Ann Rheum Dis 69:1342\u20131345","journal-title":"Ann Rheum Dis"},{"key":"755_CR24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/acr.20386","volume":"Res","author":"Kramer","year":"2011","unstructured":"Kramer HR, Giles JT (2011) Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity. Arthritis Care Res (Hoboken) 63:484\u2013499","journal-title":"Arthritis Care"},{"key":"755_CR25","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.090188","volume":"36","author":"Liang","year":"2009","unstructured":"Liang KP, Kremers HM, Crowson CS et al (2009) Autoantibodies and the risk of cardiovascular events. J Rheumatol 36:2462\u20132469","journal-title":"J Rheumatol"},{"key":"755_CR26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/art.23281","volume":"58","author":"Listing","year":"2008","unstructured":"Listing J, Strangfeld A, Kekow J et al (2008) Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 58:667\u2013677","journal-title":"Arthritis Rheum"},{"key":"755_CR27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.24390","volume":"61","author":"Lopez-Longo","year":"2009","unstructured":"Lopez-Longo FJ, Oliver-Minarro D, De La Torre I et al (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 61:419\u2013424","journal-title":"Arthritis Rheum"},{"key":"755_CR28","first-page":"1462","volume":"28","author":"Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462\u20131536","journal-title":"Eur Heart J"},{"key":"755_CR29","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","volume":"27","author":"Mancia","year":"2009","unstructured":"Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121\u20132158","journal-title":"J Hypertens"},{"key":"755_CR30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","volume":"52","author":"Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Crowson CS, Nicola PJ et al (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402\u2013411","journal-title":"Arthritis Rheum"},{"key":"755_CR31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","volume":"52","author":"Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Nicola PJ, Crowson CS et al (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722\u2013732","journal-title":"Arthritis Rheum"},{"key":"755_CR32","doi-asserted-by":"crossref","first-page":"III","DOI":"10.1007\/s00392-005-1307-x","volume":"94","author":"Mathes","year":"2005","unstructured":"Mathes P, Thiery J (2005) The role of lipid metabolism in the prevention of coronary heart disease. Z Kardiol 94(Suppl 3):III\/43\u201355","journal-title":"Z Kardiol"},{"key":"755_CR33","first-page":"127","volume":"5","author":"Matthaei","year":"2010","unstructured":"Matthaei S, Bierwirth R, Fritsche A et al (2010) Behandlung des Diabetes mellitus Typ 2. Diabetes Metab 5(Suppl 2):127\u2013132","journal-title":"Diabetes Metab"},{"key":"755_CR34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","volume":"70","author":"Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Kremers HM et al (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70:482\u2013487","journal-title":"Ann Rheum Dis"},{"key":"755_CR35","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","volume":"10","author":"Naranjo","year":"2008","unstructured":"Naranjo A, Sokka T, Descalzo MA et al (2008) Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 10:R30","journal-title":"Arthritis Res Ther"},{"key":"755_CR36","doi-asserted-by":"crossref","unstructured":"Panoulas VF, Metsios GS, Pace AV et al (2008) Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 47:1286\u20131298","DOI":"10.1093\/rheumatology\/ken159"},{"key":"755_CR37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"Peters","year":"2010","unstructured":"Peters MJL, Symmons DPM, Mccarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325\u2013331","journal-title":"Ann Rheum Dis"},{"key":"755_CR38","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1136\/ard.2009.126128","volume":"69","author":"Semb","year":"2010","unstructured":"Semb AG, Kvien TK, Aastveit AH et al (2010) Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis 69:1996\u20132001","journal-title":"Ann Rheum Dis"},{"key":"755_CR39","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1002\/art.22255","volume":"54","author":"Solomon","year":"2006","unstructured":"Solomon DH, Avorn J, Katz JN et al (2006) Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 54:3790\u20133798","journal-title":"Arthritis Rheum"},{"key":"755_CR40","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/ard.2009.122226","volume":"69","author":"Solomon","year":"2010","unstructured":"Solomon DH, Kremer J, Curtis JR et al (2010) Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 69:1920\u20131925","journal-title":"Ann Rheum Dis"},{"key":"755_CR41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/art.22094","volume":"55","author":"Suissa","year":"2006","unstructured":"Suissa S, Bernatsky S, Hudson M (2006) Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 55:531\u2013536","journal-title":"Arthritis Rheum"},{"key":"755_CR42","first-page":"CD004816","volume":"Rev","author":"Taylor","year":"2011","unstructured":"Taylor F, Ward K, Moore TH et al (2011) Statins for the primary prevention of cardiovascular disease. Cochrane database Syst Rev:CD004816","journal-title":"Cochrane database Syst"},{"key":"755_CR43","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1136\/ard.2009.110536","volume":"69","author":"Tomasson","year":"2010","unstructured":"Tomasson G, Aspelund T, Jonsson T et al (2010) Effect of rheumatoid factor on mortality and coronary heart disease. Ann Rheum Dis 69:1649\u20131654","journal-title":"Ann Rheum Dis"},{"key":"755_CR44","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S et al (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086","journal-title":"BMJ"},{"key":"755_CR45","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2008.094151","volume":"68","author":"Van","year":"2009","unstructured":"Van Halm VP, Peters MJ, Voskuyl AE et al (2009) Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 68:1395\u20131400","journal-title":"Ann Rheum Dis"},{"key":"755_CR46","doi-asserted-by":"crossref","unstructured":"Westlake SL, Colebatch AN, Baird J et al (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 49:295\u2013307","DOI":"10.1093\/rheumatology\/kep366"},{"key":"755_CR47","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/art.23811","volume":"58","author":"Wolfe","year":"2008","unstructured":"Wolfe F, Michaud K (2008) The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 58:2612\u20132621","journal-title":"Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-011-0755-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-011-0755-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-011-0755-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T08:53:51Z","timestamp":1560502431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-011-0755-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1007\/s00393-011-0755-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}